Colectomy rates for ulcerative colitis over time: Navigating the evidence in the era of precision medicine and individualised treatment

Gianluca Pellino*, Alessandro Armuzzi

*Autor corresponent d’aquest treball

Producció científica: Contribució a una revistaArticleRecercaAvaluat per experts

Resum

Nick Dai and colleagues [ [1] ] conducted an up-to-date review of the literature to assess the rates of colectomy for ulcerative colitis (UC) over time, also comparing the pre-biologic vs biologic drug eras. Indeed many clinicians and their patients hoped that biologics would reduce, or even eliminate, the need for surgery,1 and whilst a reduction in colectomy rates occurred, the effect is smaller than expected.
Idioma originalEnglish
Pàgines (de-a)1-2
Nombre de pàgines2
RevistaDigestive and Liver Disease
Volum55
Número1
DOIs
Estat de la publicacióPublicada - 1 de gen. 2023

Fingerprint

Navegar pels temes de recerca de 'Colectomy rates for ulcerative colitis over time: Navigating the evidence in the era of precision medicine and individualised treatment'. Junts formen un fingerprint únic.

Com citar-ho